Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Abstract Background To evaluate the efficacy of an intravitreal dexamethasone (IVD) implant (Ozurdex®) for the treatment of central retinal vein occlusion (CRVO) without macular edema (ME). Methods A retrospective cohort study was designed, and 20 eyes of 20 patients diagnosed with non-ischemic CRVO...
Main Authors: | Eun Young Choi, Hyun Goo Kang, Sung Chul Lee, Min Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12886-019-1097-y |
Similar Items
-
Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
by: Frederic Matonti, et al.
Published: (2012-10-01) -
To study the effect of intravitreal ozurdex implant in cases of retinal vein occlusion
by: Shailender K Chaudhary, et al.
Published: (2022-01-01) -
Combination of Ranibizumab and Dexamethasone intravitreal implant for macular edema secondary to retinal vein occlusion
by: Zhu Jing, et al.
Published: (2024-01-01) -
Efficacy of Dexamethasone intravitreal implant combined with anti-VEGF drug in the treatment of retinal vein occlusion
by: Xiao-Bo Wang, et al.
Published: (2022-10-01) -
The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario
by: Mert Simsek, et al.
Published: (2018-01-01)